| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Brad H Rovin | Q114447183 |
| P2093 | author name string | Chi Chiu Mok | |
| Huijuan Song | |||
| Lee A Hebert | |||
| Daniel J Birmingham | |||
| Hoi Wah Leung | |||
| P2860 | cites work | Update in vitamin D | Q22306211 |
| DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27 | Q28285583 | ||
| A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage | Q28287540 | ||
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey | Q31115409 | ||
| The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary | Q33729052 | ||
| Serum 25-hydroxyvitamin D levels in patients with cutaneous lupus erythematosus in a Mediterranean region | Q33878205 | ||
| Vitamin D and the immune system: new perspectives on an old theme | Q33888744 | ||
| The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3). | Q33888800 | ||
| Vitamin D: modulator of the immune system. | Q34112707 | ||
| Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? | Q34660000 | ||
| Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). | Q34886300 | ||
| Vitamin D deficiency in systemic lupus erythematosus | Q36375703 | ||
| Accelerated atherosclerosis, arterial thromboembolism, and preventive strategies in systemic lupus erythematosus | Q36461116 | ||
| The vitamin D receptor is required for iNKT cell development | Q36516149 | ||
| Control of autoimmune diseases by the vitamin D endocrine system | Q37204961 | ||
| 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification | Q37297677 | ||
| 25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus | Q37448856 | ||
| Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis | Q37457135 | ||
| Role of Vitamin D in Cardiovascular Health | Q37785121 | ||
| Westernization of Chinese adults and increased subclinical atherosclerosis | Q39519797 | ||
| Hydroxychloroquine treatment of hypercalcemia in a patient with sarcoidosis undergoing hemodialysis | Q41913606 | ||
| Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences | Q41941097 | ||
| Vitamin D insufficiency in a large female SLE cohort | Q43246258 | ||
| Photoprotective behaviour and sunscreen use: impact on vitamin D levels in cutaneous lupus erythematosus | Q46351311 | ||
| The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial | Q46557882 | ||
| Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. | Q51973496 | ||
| Systemic lupus erythematosus. | Q53495545 | ||
| P433 | issue | 4 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| vitamin | Q34956 | ||
| patient | Q181600 | ||
| vitamin D | Q175621 | ||
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 644-652 | |
| P577 | publication date | 2011-06-29 | |
| P1433 | published in | Rheumatology | Q7320492 |
| P1476 | title | Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis | |
| P478 | volume | 51 |
| Q35861014 | 25-Hydroxyvitamin D3 Deficiency Independently Predicts Cognitive Impairment in Patients with Systemic Lupus Erythematosus |
| Q51315899 | Association between low 25-hydroxyvitamin D, insulin resistance and arterial stiffness in nondiabetic women with systemic lupus erythematosus. |
| Q35399515 | Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohort. |
| Q35525108 | Atherosclerosis in systemic lupus erythematosus |
| Q28543032 | Bone disease in newly diagnosed lupus nephritis patients |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q38222914 | Correlation between serum 25(OH)D values and lupus disease activity: an original article and a systematic review with meta-analysis focusing on serum VitD confounders |
| Q37747306 | Effects of 1,25(OH)2 D3 and vitamin D receptor on peripheral CD4+ /CD8+ double-positive T lymphocytes in a mouse model of systemic lupus erythematosus |
| Q34344835 | Environmental influences on systemic lupus erythematosus expression |
| Q37339013 | Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans |
| Q37019192 | High prevalence of hypovitaminosis D of patients with autoimmune rheumatic diseases in China |
| Q26777207 | Immune Response Modulation by Vitamin D: Role in Systemic Lupus Erythematosus |
| Q38883883 | Immunomodulators in SLE: Clinical evidence and immunologic actions |
| Q46173910 | Interferon alpha gene expression and serum level association with low vitamin D levels in Egyptian female patients with systemic lupus erythematosus. |
| Q34424653 | Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up |
| Q90254289 | Metabolic determinants of lupus pathogenesis |
| Q50052184 | Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis. |
| Q35881719 | Premature atherosclerosis is associated with hypovitaminosis D and angiotensin-converting enzyme inhibitor non-use in lupus patients. |
| Q43900414 | Premature coronary heart disease in SLE: can we prevent progression? |
| Q39730854 | Prevalence and predictors of vitamin D insufficiency in supplemented and non-supplemented women with systemic lupus erythematosus in the Mediterranean region |
| Q38851096 | Preventing the development of SLE: identifying risk factors and proposing pathways for clinical care |
| Q39447041 | Raising awareness on the therapeutic role of cholecalciferol in CKD: a multidisciplinary-based opinion. |
| Q47131684 | Role of vitamin D deficiency in systemic lupus erythematosus incidence and aggravation |
| Q38993328 | Role of vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D level in Egyptian female patients with systemic lupus erythematosus |
| Q90265636 | Serum 25-hydroxyvitamin D3 levels and flares of systemic lupus erythematosus: a longitudinal cohort analysis |
| Q39964298 | Severe vitamin D deficiency increases the risk for moderate to severe disease activity in Chinese patients with SLE. |
| Q58789362 | The Impact of Vitamin D on the Immunopathophysiology, Disease Activity, and Extra-Musculoskeletal Manifestations of Systemic Lupus Erythematosus |
| Q34576314 | The clinical significance of vitamin D in systemic lupus erythematosus: a systematic review |
| Q37715242 | The effect of Vitamin D supplementation in disease activity of systemic lupus erythematosus patients with Vitamin D deficiency: A randomized clinical trial |
| Q90415132 | The effect of vitamin D on disease activity, fatigue and interferon signature gene expression in systemic lupus erythematosus |
| Q36008840 | Understanding lupus nephritis: diagnosis, management, and treatment options |
| Q38916397 | Vitamin D Deficiency and Rheumatoid Arthritis. |
| Q38727467 | Vitamin D and Its Relevance in the Etiopathogenesis of Oral Cavity Diseases |
| Q38837175 | Vitamin D and autoimmunity |
| Q90330804 | Vitamin D and connective tissue diseases |
| Q38018250 | Vitamin D and polymorphisms of VDR gene in patients with systemic lupus erythematosus |
| Q38103285 | Vitamin D and systemic lupus erythematosus: an update |
| Q38293366 | Vitamin D and systemic lupus erythematosus: continued evolution |
| Q37234685 | Vitamin D deficiency does not predict progression of coronary artery calcium, carotid intima-media thickness or high-sensitivity C-reactive protein in systemic lupus erythematosus |
| Q33833563 | Vitamin D in inflammatory diseases |
| Q37432921 | Vitamin D receptor gene BsmI polymorphisms in Egyptian children and adolescents with systemic lupus erythematosus: A case-control study |
| Q36511431 | Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus. |
| Q36583806 | Vitamin d deficiency in patients with systemic lupus erythematosus |
| Q44125096 | What's new in internal medicine? |
Search more.